Pfizer to close Mumbai manufacturing facility

By Zachary Brennan contact

- Last updated on GMT

Related tags: India, Andhra pradesh, Maharashtra

Pfizer to close Mumbai manufacturing facility
With no active production at the plant since 2013, the company said it would shutter its Mumbai, India-based facility in mid-September, according to a Bombay Stock Exchange filing. 

The decision to close the Plant is based on an assessment of its long term viability and its ability to achieve the needed production​,” Pfizer said. “There has practically been no production activity at this plant since 2013, and the closure will not impact the supply of any of the Company's medicines to patients​.”

All of Pfizers' employees at the 50-year-old plant were offered a voluntary retirement scheme last year, and 132 out of 212 took the option. The company said the remaining workers continue to receive full wages despite the plant’s inactivity.

The closure comes as Pfizer’s recent acquisition of Hospira brings along with it an injectables plant in the Andhra Pradesh region of India​, which earlier this month got the go-ahead from the FDA to begin commercial production.

Related news

Show more

Related products

Vaccine Innovation in the Era of COVID19

Vaccine Innovation in the Era of COVID19

Covance Patient Safety | 01-Oct-2020 | Sponsored Link

During this time of worldwide crisis, there is an increasing demand for the acceleration of a vaccination for COVID19. Regardless of the great recent advancements...

Lactium, your ally to manage day to day stress

Lactium, your ally to manage day to day stress

Ingredia | 27-Aug-2020 | Product Presentation

Stress has been called the ‘health epidemic of the 21st century’ by the World Health Organization. Increasingly, consumers are looking for safe, reliable...

Related suppliers

Follow us

Products

View more

Webinars